OMO. S. Michael

O. S. Michael

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


O. S. Michael has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Ae Orimadegun

    Institute of Child Health, College of Medicine, University of Ibadan, Ibadan, Nigeria

    1 shared publication
  • As Jegede

    Department of Sociology, Faculty of the Social Sciences, University of Ibadan, Ibadan, Nigeria

    1 shared publication
  • Catherine Olufunke Falade

    Department of Pharmacology and Therapeutics, University of Ibadan, Ibadan, Nigeria

    1 shared publication
  • Co Falade

    Department of Pharmacology and Therapeutics; Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria

    1 shared publication
  • F. Olojede

    Department of Pharmacology and Therapeutics University of Ibadan, Ibadan, Nigeria

    1 shared publication
  • Fi Olusola

    Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria

    1 shared publication

Latest Publications

  • Open Access

    Comparative Evaluation of Three Histidine-Rich Protein-2 Based Rapid Diagnostic Tests, Microscopy and PCR for Guiding Malaria Treatment in Ibadan, Southwest Nigeria

    by Ae Orimadegun, Ri Funwei, Os Michael, Oo Ogunkunle, Ja Badejo, Fi Olusola, O Agede, Oe Anjorin, Io Ajayi, As Jegede, et al.

    Background: Malaria rapid diagnostic tests (mRDTs) are the preferred option for programmatic deployment. Aims: There are numerous mRDTs on the Nigerian market and there is a need to guide practitioners on the relative performance of the commonly used brands of mRDT in Nigeria. Subjects and Methods: The performance of three commonly used Histidine-Rich-Protein-2-based mRDTs (SD-Bioline™, Carestart™ and Paracheck-Pf™) against microscopy of Giemsa stained blood and polymerase chain reaction (PCR) was evaluated among 190 febrile under-5 children in Ibadan, Nigeria. We calculated the sensitivity, specificity, predictive values, accuracy, and agreements. Results: There were 53.2% males. The prevalence of malaria parasite by microscopy was 46.8% and 57.9% by PCR. Malaria parasite detection by SD-Bioline™ was 60.5%, Carestart™: 60.0% and Paracheck-Pf™ 60.0%. Using microscopy as the gold standard, the sensitivities of SD-Bioline™, Carestart™ and Paracheck-Pf™ mRDT were 97.8%, 96.7% and 97.8% respectively while the specificities were 73.0%, 72.0% and 74.0% respectively. Using PCR as the gold standard, the sensitivity for both SD-Bioline™ and Paracheck-Pf™ was 85.5% and for CareStart was 84.6% while the specificity of SD-Bioline™, Carestart™, and Paracheck-Pf™ was 73.8%, 72.4%, and 75.0% respectively. The test accuracy was 81.0% for both SD-Bioline™ and Paracheck-Pf™ and 80.0% for Caresatrt™. The kappa coefficient of agreement between PCR and each of SD-Bioline™, Carestart, ParaCheck™ and microscopy was 0.597, 0.578, 0.609 and 0.739 respectively. Conclusion: The performance of the three mRDTs is a proof that any of the three is suitable for use in the diagnosis of malaria in the southwest of Nigeria.


  • Blood banking in a malaria-endemic area: evaluating the problem posed by malarial parasitaemias

    by C. O. Falade, O. Nash, T. S. Akingbola, O. S. Michael, F. Olojede, O. G. Ademowo

    The emergence and wide dissemination of drug-resistant malarial parasites underscore the need to prevent post-transfusion malaria. In Nigeria, as in most of sub-Saharan Africa, however, blood donors are not routinely screened for malarial infection. Recently, 391 consecutive potential blood donors in a malaria-endemic area of south-western Nigeria were each checked for malarial parasitaemia using three methods: microscopy (all samples), OptiMAL (315 samples) and/or the Clinotech Malaria Cassette (142 samples). OptiMAL detects parasite-specific lactate dehydrogenase whereas the Clinotech test detects the surface proteins of merozoites and sporozoites. Microscopy revealed parasitaemias in 79 (20.2%) of the potential donors, the levels of parasitaemia varying from 34 to 6289 asexual parasites/microl (mean=445/microl). The prevalence of malarial parasitaemia, as detected by microscopy, was significantly higher during the rainy season than in the dry season (27.3% v. 5.5%; P or =37.5 degrees C), blood group, gender or anaemia. The corresponding prevalences of malarial parasitaemia detected using the rapid diagnostic tests were 3.8% (12/315) for OptiMAL and 57.8% (82/142) for the Clinotech. With the results of the microscopy used as the 'gold standard', OptiMAL gave a sensitivity of only 16.0% but a specificity of 98.5%. The corresponding values for the Clinotech tests were 69.2% and 50.0%, respectively. It would clearly be beneficial to include screening for malaria parasitaemia in the routine investigation of potential blood donors in Nigeria, especially during the rainy season, when the risk of transfusion-transmitted malaria appears relatively high.